Literature DB >> 3944596

Co-morbidity and depression among the anxiety disorders. Issues in diagnosis and classification.

D H Barlow, P A DiNardo, B B Vermilyea, J Vermilyea, E B Blanchard.   

Abstract

One hundred twenty-six patients presenting at an anxiety disorders research clinic were administered a structured interview. Diagnoses were made on the basis of DSM-III criteria but without regard to current exclusionary systems within DSM-III. Rather, clinicians decided whether anxiety and depressive symptoms that met DSM-III criteria for additional diagnoses were associated features of the presenting problem or represented an independent coexisting complication. Diagnoses and accompanying psychometric data delineated groups of patients with somewhat different clinical and psychometric characteristics. But additional anxiety and depressive diagnoses were required in a number of cases. Anxiety states almost always required additional diagnoses whereas for the phobic disorders additional diagnoses occurred less frequently. Simple and social phobia were the most frequent additional diagnoses, but depression was more strongly associated with some anxiety disorders, specifically obsessive-compulsive disorder. In view of the treatment implications of comorbidity, establishing the functional relationships among anxiety symptoms without regard to exclusionary systems would seem important in both clinical and research settings.

Entities:  

Mesh:

Year:  1986        PMID: 3944596     DOI: 10.1097/00005053-198602000-00001

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  14 in total

1.  A study of comorbidity in psychoactive substance dependence patients.

Authors:  P Kisore; N Lal; J K Trivedi; P K Dalal; V M Aga
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

Review 2.  Using family studies to understand comorbidity.

Authors:  P J Wickramaratne; M M Weissman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 3.  A risk-benefit assessment of buspirone in the treatment of anxiety disorders.

Authors:  J C Pecknold
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

4.  Anxiety disorders in a French general psychiatric outpatient sample. Comparison between DSM-III and DSM-IIIR criteria.

Authors:  J P Lepine; P Pariente; J P Boulenger; P Hardy; E Zarifian; T Lemperiere; J Lellouch
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1989-11       Impact factor: 4.328

5.  Rationale and principles for early intervention with young children at risk for anxiety disorders.

Authors:  Dina R Hirshfeld-Becker; Joseph Biederman
Journal:  Clin Child Fam Psychol Rev       Date:  2002-09

6.  Anxiety disorders in African-American and white children.

Authors:  C G Last; S Perrin
Journal:  J Abnorm Child Psychol       Date:  1993-04

Review 7.  Specificity of trait anxiety in anxiety and depression: Meta-analysis of the State-Trait Anxiety Inventory.

Authors:  Kelly A Knowles; Bunmi O Olatunji
Journal:  Clin Psychol Rev       Date:  2020-10-10

8.  Psychosocial stress and anxiety in musculoskeletal pain patients with and without depression.

Authors:  Ellen L Poleshuck; Matthew J Bair; Kurt Kroenke; Teresa M Damush; Wanzhu Tu; Jingwei Wu; Erin E Krebs; Donna E Giles
Journal:  Gen Hosp Psychiatry       Date:  2008-11-22       Impact factor: 3.238

9.  Attention modification program in individuals with generalized anxiety disorder.

Authors:  Nader Amir; Courtney Beard; Michelle Burns; Jessica Bomyea
Journal:  J Abnorm Psychol       Date:  2009-02

10.  Screening for anxiety disorders in children.

Authors:  Ellin Simon; Susan Maria Bögels
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-05-05       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.